H. Sunamoto

Novel Oral Derivative UD-017, a Highly Selective CDK7 Inhibitor, Exhibits Anticancer Activity by Inducing Cell-Cycle Arrest and Apoptosis in Human Colorectal Cancer

M. Yoshizumi, H. Kokubo, F. Nara, 2020 .

The CCG1/TAFII250 gene is mutated in thermosensitive G1 mutants of the BHK21 cell line derived from golden hamster.

E. Noguchi, T. Nishimoto, T. Sekiguchi, 1994, Gene.

Novel Keap1-Nrf2 Protein-Protein Interaction Inhibitor UBE-1099 Ameliorates Progressive Phenotype in Alport Syndrome Mouse Model

M. Suico, T. Shuto, H. Kai, 2021, Kidney360.

Structure of the human CCG1 gene: relationship between the exons/introns and functional domain/modules of the protein.

D. Schlessinger, J. Kere, K. Yura, 1994, Gene.

Abstract 4837: Evaluation of anticancer activities of UD-017, a novel selective and orally available CDK7 inhibitor, in blood cancers

N. Iwase, Y. Aga, K. Onuma, 2018, Experimental and Molecular Therapeutics.

Abstract 4835: UD-017, a novel highly selective and orally active CDK7 inhibitor, shows a significant anticancer activity in patient-derived cancers

Y. Aga, K. Onuma, S. Ushiyama, 2018, Experimental and Molecular Therapeutics.

Abstract LB-111:In vitroanti-cancer activity of UD-017, a novel potent & highly selective CDK7 reversible inhibitor

N. Iwase, Y. Aga, K. Onuma, 2017 .

Preclinical in vitro and in vivo study of UD-017, a novel highly selective and orally available CDK7 inhibitor, in a variety of cancers.

Y. Aga, K. Onuma, S. Ushiyama, 2017 .